USPTO serial 86704182
MUSTANG BIO
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BURNS, ELLEN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MUSTANG BIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Devon E. White
DEVON E. WHITE Wyrick Robbins Yates & Ponton Llp4101 Lake Boone Trl Ste 300Raleigh, NC 27607-7525UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical, biological and pharmaceutical preparations for medical or pharmaceutical use, namely, preparations for the treatment of cancer, autoimmune diseases and disorder, rare diseases, genetic diseases, infectious diseases, central nervous system infections, gastrointestinal infections, genitourinary infections, ocular infections, dermatological infections, immune system infections, liver infections, hepatic infections, neurological disorders, tuberculosis, lung diseases, asthma, hypertension, cardiovascular diseases, immunologic diseases, immunologic deficiency syndromes, tumors, proliferative diseases, inflammatory diseases, inflammatory bowel diseases, inflammatory connective tissue diseases, psoriasis, ophthalmologic diseases, fibrotic diseases, metabolic diseases, dental and oral diseases, neurological diseases, Alzheimer´s disease, Huntington´s disease, Parkinson, cerebral palsy, brain injury, spinal cord injury, seizure disorders, congenital disorders, metabolic disorders, viral and infectious diseases and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of genetic and congenital disorders, metabolic disorders, infectious diseases, cancer and pain relief; Pharmaceutical products for the treatment and normalization of disorders of the body's circulatory system; Pharmaceutical products for the treatment of diseases of the blood or of the lymphatic circulatory system; Pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 6, 2019 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 6, 2019 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 21, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 20, 2018 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Sep 20, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 11, 2018 | EXT5 | SOU EXTENSION 5 FILED | — |
| Sep 11, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 30, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 28, 2018 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Mar 28, 2018 | EXT4 | SOU EXTENSION 4 FILED | — |
| Mar 28, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 5, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 3, 2017 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Oct 3, 2017 | EXT3 | SOU EXTENSION 3 FILED | — |
| Oct 3, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 15, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 13, 2017 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 13, 2017 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 13, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 9, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 7, 2016 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 7, 2016 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 7, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 5, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 9, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 9, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 20, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 4, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 4, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 4, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 4, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 4, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 4, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 31, 2015 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Jul 30, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 28, 2015 | NWAP | NEW APPLICATION ENTERED | — |